| References |
Bonaldo et al., 2000: Bonaldo MC, Caufour PS, Freire MS, Galler R. The yellow fever 17D vaccine virus as a vector for the expression of foreign proteins: development of new live flavivirus vaccines. Memorias do Instituto Oswaldo Cruz. 2000; 95 Suppl 1; 215-223. [PubMed: 11142718].
Franco et al., 2010: Franco D, Li W, Qing F, Stoyanov CT, Moran T, Rice CM, Ho DD. Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development. Vaccine. 2010; 28(35); 5676-5685. [PubMed: 20600494].
Galler et al., 1997: Galler R, Freire MS, Jabor AV, Mann GF. The yellow fever 17D vaccine virus: molecular basis of viral attenuation and its use as an expression vector. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.]. 1997; 30(2); 157-168. [PubMed: 9239300].
Xiaowu et al., 2006: Xiaowu P, Fu WC, Guo YH, Zhang LS, Xie TP, Xinbin G. [Construction of recombinant yellow fever virus 17D containing 2A fragment as a vaccine vector]. Sheng wu gong cheng xue bao = Chinese journal of biotechnology. 2006; 22(3); 492-498. [PubMed: 16755933].
|
